Clinico-Pathologic Correlation in Non-Hodgkin's Lymphoma: III. Biologic significance of a modified Lukes and Collins classification

Reference

• Berard C. W., Jaffe E. S., Braylan R. C., Mann R. B., Nanba K. Immunologic aspects and pathology of the malignant lymphomas. Cancer 1978; 42: 911
   PubMed Web of Science ®Google Scholar
• Bloomfield C. D., Kersey J. H., Brunning R. D., Gajl-Peczalska K. J. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma. Cancer Treat. Rep. 1977; 61: 963
   PubMedGoogle Scholar
• Bom-van Noorloos A. A., Splinter T. A. W., van Heerde P., van Beek A. A. M., Melief C. J. M. Surface markers and functional properties of non-Hodgkin's lymphoma cells in relation to histology. Cancer 1978; 42: 1804
   PubMedGoogle Scholar
• Braylan R. C., Jaffe E. S., Berard C. W. Malignant lymphomas. Current classification and new observations. Pathology annual, S. C. Sommers. Appleton-Century-Crofts, New York 1975; Vol. 10: 213
   Google Scholar
• Braylan R. C., Fowlkes B. J., Jaffe E. S., Sanders S. K., Berard C. W., Herman C. J. Cell volumes and DNA distributions of normal and neoplastic human lymphoid cells. Cancer 1978; 41: 201
   PubMed Web of Science ®Google Scholar
• Coccia P. F., Kersey J. H., Gajl-Peczalska K. J., Krivit W., Nesbit M. E. Prognostic significance of surface marker analysis in childhood non-Hodgkin's lymphoproliferative malignancies. Amer. J. Hematol. 1976; 1: 405
   PubMedGoogle Scholar
• Colton T. Statistics in medicine. Little, Brown & Co, Boston 1974; 174
   Google Scholar
• Donlon J. A., Jaffe E. S., Braylan R. C. Terminal deoxynucleotidyl transferase activity in malignant lymphomas. New Engl. J. Med. 1977; 297: 461
   PubMed Web of Science ®Google Scholar
• Galton D. A. G. Chronic lymphocytic leukemia. Its pathogenesis and relationship to lymphosarcoma. Symposium on Lymphoid Tumours in Africa, F. C. Roulet, S. Karger. Basel, New York 1964; 163
   Google Scholar
• Catovsky Galton D.A.G.D., Wiltshaw E. Clinical spectrum of lymphoproliferative diseases. Cancer 1978; 42: 901
   PubMedGoogle Scholar
• Huber Ch., Michlmayr G., Huber H., Braunsteiner H. Zur Differenzierung von Non-Hodgkin-Lymphomen mit immunologischen, zellkinetischen und physikalischen Methoden. Dtsch. med. Wschr. 1977; 102: 1795
   PubMedGoogle Scholar
• Jaffe E. S., Berard C. W. Lymphoblastic lymphoma, a term rekindled with new precision. Ann. intern. Med. 1978; 89: 415
   PubMed Web of Science ®Google Scholar
• Braylan E. S., Jaffe R. C., Frank M. M., Green I., Berard C. W. Heterogeneity of immunologic markers and surface morphology in childhood lymphoblastic lymphoma. Blood 1976; 48: 213
   PubMedGoogle Scholar
• Braylan E. S., Jaffe R. C., Nanba K., Frank M. M., Berard C. W. Functional markers. A new perspective on malignant lymphomas. Cancer Treat. Rep. 1977; 61: 953
   PubMedGoogle Scholar
• Kaplan J., Mastrangelo R., Peterson W. D. Childhood lymphoblastic lymphoma, a cancer of thymus-derived lymphocytes. Cancer Res. 1974; 34: 521
   PubMed Web of Science ®Google Scholar
• Kersey I., Sabad A., Gajl-Peczalska K. J. Neoplastic cells from childhood lymphoblastic leukemia and lymphoma with T and B lymphocyte markers. Amer. J. Path. 1974; 74: 64
   Google Scholar
• Lenner P., Lundgren E., Damber L. Clinico-pathologic correlation in non-Hodgkin's lymphoma.I. Retrospective analysis using the Lukes and Collins classification. Acta radiol. Oncology 1979; 18: 177
   Google Scholar
• Lenner P., Lundgren E., Damber L. Clinico-pathologic correlation in non-Hodgkin's lymphoma.II. Clinical and prognostic significance of nodularity. Acta radiol. Oncology 1979; 18: 417
   Google Scholar
• Lennert K. Classification of non-Hodgkin's lymphomas. Malignant lymphomas other than Hodgkin's disease. Histology, cytology, ultrastructure, immunology, K. Lennert, N. Mohri, H. Stein, E. Kaiserling, H. K. Müller-Hermelink. Springer-Verlag, Berlin, Heidelberg, New York 1978; 83
   Google Scholar
• Li C., Harrison E. G., Jr. Histochemical and immunohistochemical study of diffuse large-cell lymphomas. Amer. J. clin. Pathol. 1978; 70: 721
   PubMed Web of Science ®Google Scholar
• Lukes R. J., Collins R. D. New observations on follicular lymphoma. Malignant diseases of the hematopoietic system. Gann monograph on cancer research, K. Akazaki, H. Rappaport, C. W. Berard, J. M. Bennett, E. Ishikawa. University of Tokyo Press, Tokyo 1973; 209, No. 15
   Google Scholar
• Lukes R. J., Collins R. D. Immunologic characterization of human malignant lymphomas. Cancer 1974; 34: 1488
   PubMed Web of Science ®Google Scholar
• Lukes R. J., Collins R. D. A functional approach to the classification of malignant lymphoma. Recent results in cancer research. Springer-Verlag, Berlin, Heidelberg, New York 1974; Vol. 46: 18
   Google Scholar
• Lukes R. J., Collins R. D. New approaches to the classification of the lymphomata. Brit. J. Cancer 1975; 31(No. II)1, Suppl.
   PubMedGoogle Scholar
• Lukes R. J., Collins R. D. Lukes-Collins classification and its significance. Cancer Treat. Rep. 1977; 61: 971
   PubMedGoogle Scholar
• Lukes Parker R. J. J. W., Taylor C. R., Tindle B. H., Cramer A. D., Lincoln T. L. Immunologic approach to non-Hodgkin lymphomas and related leukemias. Analysis of the results of multiparameter studies of 425 cases. Semin. Hematol. 1978; 15: 322
   PubMedGoogle Scholar
• Lukes Taylor R. J. C. R., Parker J. W., Lincoln T. L., Pattengale P. K., Tindle B. H. A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias. Amer. J. Path. 1978; 90: 461
   PubMedGoogle Scholar
• Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. W., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Brit. J. Cancer 1976; 34: 585
   PubMed Web of Science ®Google Scholar
• Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. W., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Brit. J. Cancer 1977; 35: 1
   PubMed Web of Science ®Google Scholar
• Rappaport H., Winter W. J., Hicks E. B. Follicular lymphoma. A re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases. Cancer 1956; 9: 792
   PubMed Web of Science ®Google Scholar
• Sen L., Borella L. Clinical importance of lymphoblasts with T markers in childhood acute leukemica. New Engl. J. Med. 1975; 292: 828
   PubMed Web of Science ®Google Scholar
• Stein H. The immunologic and immunochemical basis for the Kiel classification. Malignant lymphomas other than Hodgkin's disease. Histology, cytology, ultrastructure, immunology, K. Lennert, N. Mohri, H. Stein, E. Kaiserling, H. K. Müller-Hermelink. Springer-Verlag, Berlin, Heidelberg, New York 1978; 529
   Google Scholar
• Stein Petersen H. N., Gaedicke G., Lennert K., Landbeck G. Lymphoblastic lymphoma of convoluted or acid phosphatase type. A tumor of T precursor cells. Int. J. Cancer 1976; 17: 292
   PubMedGoogle Scholar
• Taylor C. R. Classification of lymphoma. New thinking on old thoughts. Arch. Path. Lab. Med. 1978; 102: 549
   PubMed Web of Science ®Google Scholar
• Tsukimoto I., Wong K. Y., Lampkin B. C. Surface markers and prognostic factors in acute lymphoblastic leukemia. New Engl. J. Med. 1976; 294: 245
   PubMed Web of Science ®Google Scholar
• Whiteside T. L., Rowlands D. T., Jr. T-cell and B-cell identification in the diagnosis of lymphoproliferative disease. A review. Amer. J. Path. 1977; 88: 754
   PubMedGoogle Scholar